N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride, 95.0%, 5g

2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate, 95%, 10g

(S)-2-Acetamido-6-((tert-butoxycarbonyl)amino)hexanoic acid, 95.0%, 10g

D-Camphor, 95.0%, 10g

(2S,4S)-tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate, 95.0%, 10g

3-Amino-1H-indole-2-carboxylic acid ethyl ester, 95.0%, 10g

4-Bromo-1H-inden-2(3H)-one, 95.0%, 250mg

Conjunto de polarización. El analizador se coloca sobre el ocular y una estrecha mesa giratoria de 360° con polarizador incorporado.

4-Benzyloxy-2-chlorophenylboronic acid, 95.0%, 1g

N-FMOC-L-ASPARTIC ACID 1-(9-FLUORENYLMETHYL) ESTER, 95%, 5g

Ethyl 2-bromo-3-fluorobenzoate, 25g

h-dl-nle-oh, 98.0%, 100g

4-Bromo-2-methoxyphenol>97.0%(GC)(T)5g